Lamivudine 150mg Tablet Franchise in Ahmedabad

Hepatitis B Antiviral Supplier in Mumbai

Lamicone 150 Tablet Distributor in Delhi

Lamivudine Tablet Franchise Opportunity in Bangalore

Hepatitis Treatment Tablet Stockist in Hyderabad
Lamivudine 150mg Export & Manufacturing in Chandigarh

Home/Products /lamivudine-150mg-tablet

Lamicone 150 Tablet

Composition : Lamivudine (150mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Lamicone 150 Tablet contains Lamivudine 150mg, a potent antiviral medication primarily indicated for the management of Hepatitis B infection. It helps in controlling viral replication, reducing viral load, and maintaining healthy liver function.

Lamivudine works by inhibiting the reverse transcriptase enzyme of the Hepatitis B virus, slowing disease progression, and supporting overall liver health. It is widely recommended by hepatologists and gastroenterologists for chronic Hepatitis B patients.

For distributors and healthcare suppliers, Lamicone 150 Tablet is a high-demand antiviral therapy product, frequently prescribed in clinics, hospitals, and specialized liver care centers. Rising awareness of Hepatitis B and the need for effective management ensure consistent market demand.

Adding Lamicone 150 Tablet to your hepatoprotective and antiviral segment offers significant opportunities in pharmacies, hospitals, liver clinics, export markets, and third-party manufacturing. Its clinical efficacy, patient acceptance, and broad application make it a valuable addition for pharmaceutical distribution.

Read More

About the Product

Lamicone 150 Tablet contains Lamivudine 150mg, a potent antiviral medication primarily indicated for the management of Hepatitis B infection. It helps in controlling viral replication, reducing viral load, and maintaining healthy liver function.

Lamivudine works by inhibiting the reverse transcriptase enzyme of the Hepatitis B virus, slowing disease progression, and supporting overall liver health. It is widely recommended by hepatologists and gastroenterologists for chronic Hepatitis B patients.

For distributors and healthcare suppliers, Lamicone 150 Tablet is a high-demand antiviral therapy product, frequently prescribed in clinics, hospitals, and specialized liver care centers. Rising awareness of Hepatitis B and the need for effective management ensure consistent market demand.

Adding Lamicone 150 Tablet to your hepatoprotective and antiviral segment offers significant opportunities in pharmacies, hospitals, liver clinics, export markets, and third-party manufacturing. Its clinical efficacy, patient acceptance, and broad application make it a valuable addition for pharmaceutical distribution.

Some patients may experience mild side effects including headache, nausea, fatigue, or abdominal discomfort. Rarely, severe side effects such as lactic acidosis, hepatomegaly with steatosis, or pancreatitis can occur. Patients should consult their healthcare provider if any unusual or persistent symptoms appear.

Lamicone 150 Tablet is indicated for the treatment of chronic hepatitis B infection in adults and adolescents. It helps in reducing viral load, improving liver enzyme levels, and minimizing the risk of long-term liver damage caused by persistent HBV infection.

Before taking Lamicone 150 Tablet, inform your doctor about any existing liver or kidney problems, or if you are pregnant or breastfeeding. Do not discontinue the medication abruptly without medical advice, as it may cause viral rebound. Routine monitoring of liver function tests and viral load is recommended during therapy.

Store Lamicone 150 Tablet in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children and ensure the container is tightly sealed. Do not use the medication beyond its expiration date.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation